Skip to main content
SpringerLink
Log in
Book cover

Blood Conservation in Cardiac Surgery pp 187–209Cite as

Blood Conservation for Infants and Children Undergoing Surgery for Acquired and Congenital Heart Diseases

  • Chapter

  • 178 Accesses

Abstract

Surgery for congenital heart disease dates to the very birth of the practice of clinical cardiac surgery in the early 1930s. In spite of this fact, the ability to conserve the use of blood products and to preserve the patient’s own circulating red blood cell mass has been one of the major challenges facing cardiac surgeons today. Although many lessons have been learned and applied from the practice of adult cardiac surgical blood conservation including mechanical, pharmacologic, and adjunctive measures, professionals treating children with congenital heart disease realized very quickly that they are not small adults, and therefore special challenges and special technical and pharmacologic considerations are required.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Tsang VT, Mullaly RJ, Ragg PG, et al. Bloodless open-heart surgery in infants and children.Perfusion 1994(4):257–263.

    Google Scholar 

  2. Evans DA, Holder RL, Brawn WJ, et al. Post-operative blood loss following cardio-pulmonary bypass in children.Eur J Cardiothorac Surg 1994;8(1):25–29.

    PubMed  CAS  Google Scholar 

  3. Maeda M, Koyama T, Murase M, et al. The indications and limitations of open heart surgery without homologous blood transfusion in children and infants.Nippon Kyobu Geka Gakkai Zasshi 1994;42(1):1–7.

    PubMed  CAS  Google Scholar 

  4. Tasaki T, Ohto H, Noguchi M, et al. Autologous blood donation elective surgery in children.Vox Sang 1994;66(3):188.

    PubMed  CAS  Google Scholar 

  5. Kharasch SJ, Millham F, Vinci RJ. The use of autotransfusion in pediatric chest trauma.Pediatr Emerg Care 1994;10(2):109–112.

    PubMed  CAS  Google Scholar 

  6. Berniere J. Evolution of blood transfusion economy techniques in pediatric orthopedic surgery.Arch Pediatr 1995;2(2):108–110.

    PubMed  CAS  Google Scholar 

  7. Budny PG, Regan PJ, Roberts AH. The estimation of blood loss during burns surgery.Burns 1993;19(2):134–137.

    PubMed  CAS  Google Scholar 

  8. Carlier M, Van Obbergh LJ, Veyckemans F, et al. Hemostasis in children undergoing liver transplantation.Somin Thromb Hemost 1993;19(3):218–222.

    CAS  Google Scholar 

  9. Simpson MB, Georgopoulos G, Eilert RE. Intraoperative blood salvage in children and young adults undergoing spinal surgery with predeposited autologous blood: efficacy and cost effectiveness.J Pediatr Orthop 1993;13(6):777–780.

    PubMed  CAS  Google Scholar 

  10. Griffin TC, Buchanan GR. Elective surgery in children with sickle cell disease without preoperative blood transfusion. J Pediatr Surg 1993;28(5):681–685.

    PubMed  CAS  Google Scholar 

  11. Aleksandrov AE, Lekmanov AU, Leont’ev AF, et al. Risk factors and their correction during shunt operation in children with extrahepatic portal hypertension.Anestezio Reanimatol 1994;3:8–10.

    Google Scholar 

  12. Presson RB Jr, Hillier SC. Perioperative fluid and transfusion management.Semin Pediatr Surg 1992;1(1);22–31.

    PubMed  Google Scholar 

  13. Sobrinho AF, Baucia JA, Tranquitelle AM, et al. Pediatric heart surgery in a general hospital. Procedures and results in a 5 years’ experience.Arq Bras Cardiol 1993;61(1):17–22.

    PubMed  CAS  Google Scholar 

  14. Tsang VT, Mullaly RJ, Ragg PG, et al. Bloodless open-heart surgery in infants and children.Perfusion 1994;9(4):257–263.

    PubMed  CAS  Google Scholar 

  15. Kawagicki M, Bergsland J, Subramanian S. Total bloodless open heart surgery in the pediatric age group.Circulation 1984;70(supp I):37.

    Google Scholar 

  16. Taylor KM. Perioperative approaches to coagulation defects.Ann Thorac Surg 1993;56(5 suppl):S78–S82.

    PubMed  CAS  Google Scholar 

  17. Fleming RY, Herndon DN, Vaidya S, et al. The effect of erythropoietin in normal healthy volunteers and pediatric patients with bum injuries.Surgery 1992;112(2):424–431.

    PubMed  CAS  Google Scholar 

  18. Hayshi J, Shinonaga M, Nakazawa S, et al. Does recombinant human erythropoietin accelerate erythropoiesis for predonation before cardiac surgery?Jpn Circ J 1993;57(6):475–479.

    Google Scholar 

  19. Schmoeckel M, Nollert G, Mempel M, et al. Effects of recombinant human erythropoietin on autologous blood donation before open heart surgery. Thorac Cardiovasc Surg 1993;41(6):364–368.

    PubMed  CAS  Google Scholar 

  20. Seracini D, Pollini I, Lavoratti GC, et al. An echocardiographic study of the left ventricular functional indices in pediatric patients on hemodialysis and in treatment with recombinant human erythropoietin.Pediatr Med Chir 1994;16(4):389–392.

    PubMed  CAS  Google Scholar 

  21. Helm RE, Gold JP, Rosengart TK, et al. Erythropoietin in cardiac surgery.J Cardiovasc Surg 1993;8(5):579–606.

    CAS  Google Scholar 

  22. Horiba K, Itou Y, Terada H, et al. Experience of predeposit autologous blood transfusion and medication of recombinant human erythropoietin in pediatric open heart surgery.Kyobu Geka 1991;44(13):1146–1150.

    PubMed  CAS  Google Scholar 

  23. Triulzi DJ, Gilmor, GD, Ness PM, et al. Efficacy of autologous fresh whole blood or platelet-rich plasma in adult cardiac surgery.Transfusion 1995;35(8):67–634.

    Google Scholar 

  24. Kemmotsu H, Joe K, Nakamura H, et al. Predeposited autologous blood transfusion for surgery in infants and children.J Pediatr Surg 1995;30(5):659–661.

    PubMed  CAS  Google Scholar 

  25. Zanolli FA, Scremin A, Negri MG, et al. Predeposit hemodilution and intra- and post-operative blood salvage in the orthopaedic surgery of brain damaged children.Int J Artif Organs 1993;16(suppl 5):247–252.

    PubMed  Google Scholar 

  26. Flynn JM, Cintron K, Canals RM. The use of autologous blood transfusions in pediatric orthopaedic surgery.Bol Assoc Med P R 1991;83(5):192.

    CAS  Google Scholar 

  27. Strauss RG, Wieland MR, Randels MJ, et al. Feasibility and success of a single-donor red cell program for pediatric elective surgery patients.Transfusion 1992;32(8):747–749.

    PubMed  CAS  Google Scholar 

  28. Drink water DC, Laks H. Pediatric cardioplegic techniques.Semin Thorac Cardiovasc Surg 1993;5(2):168–175.

    PubMed  CAS  Google Scholar 

  29. Milne AA, Murphy WG, Reading SJ, et al. Fibrin sealant reduces suture line bleeding during carotid endoarterectomy: a randomized trial.Eur J Vase EndovascSurg 1995;10(1):91–94.

    CAS  Google Scholar 

  30. Tabuchi N, deHoan J, van Oeveren W. Topical effect of aprotinin on the surgical wound in cardiac surgery.J Thorac Cardiovasc Surg 1995;109(2):400–402.

    Google Scholar 

  31. O’Regan DJ, Giannopoulos N, Mediratta N, et al. Topical aprotinin in cardiac operations.Ann Thorac Surg 1994;58(3):778–781.

    PubMed  Google Scholar 

  32. Cicek S, Tatar H, Demirkilic U, et al. Topical use of aprotinin in cardiac surgery. J Thorac Cardiovasc Surg 1995;110(2):568–569.

    PubMed  CAS  Google Scholar 

  33. Gontijo B, Fantini FA, Alcocer EP, et al. Secondary sternotomy in pediatric hear surgery.Arq Bras Cardiol 1994;62(2):103–106.

    PubMed  CAS  Google Scholar 

  34. Achauer BM, Miller SR, Lee TE, e al. The hemostatis effect of fibrin glue on graft donor sites.J Burn Care Rehabil 1994;15(1):24–28.

    PubMed  CAS  Google Scholar 

  35. Beppu T, Imai Y, Fukui A. A computerized control system for cardiopulmonary bypass.J Thorac Cardiovasc Surg 1995;109(3):428–438.

    PubMed  CAS  Google Scholar 

  36. Hill AG, Green RC, Abe BF, et al. Pediatric perfusion practice in North America.Perfusion 1993;8:29.

    Google Scholar 

  37. Friesen RH, Tornabene MA, Coleman SP. Blood conservation during pediatric cardiac surgery: ultrafiltration of the extracorporeal circuit volume after cardiopulmonary bypass.Anesth Analg 1993;77(4):702–707.

    PubMed  CAS  Google Scholar 

  38. Yoshikawa Y, Niwaya K, Hasegawa J, et al. Effect of blood conservation in open-heart surgery: a comparison of 3 different methods.Kyobu Geka 1994;47(13):1059–1062.

    PubMed  CAS  Google Scholar 

  39. Honek T, Horvath P, Kucera V, et al. Minimisation of priming volume and blood saving in paediatric cardiac surgery.Eur J Cardiothorac Surg 1992;6(6):308–310.

    PubMed  CAS  Google Scholar 

  40. Bilfinger TV, Moeller JR, Kurusz M, et al. Pediatric myocardial protection in the United States: a survey of current clinical practice.Thorac Cardiovasc Surg 1992;40(4):214–218.

    PubMed  CAS  Google Scholar 

  41. Hirschi RB. Oxygen delivery in the pediatric surgical patient.Curr Opin Pediatr 1994;6(3):341–347.

    Google Scholar 

  42. Yau TM, Carson S, Weisel RD, et al. The effect of warm heart surgery on postoperative bleeding.J Thorac Cardiovasc Surg 1992;103(6):1155–1163.

    PubMed  CAS  Google Scholar 

  43. van Iterson M, van der Waart FJ, Erdmann W, et al. Systemic haemodynamics and oxygenation during haemodilution in children.Lancet 1995;346(8983):1127–1129.

    PubMed  Google Scholar 

  44. Wajon PR, Walsh RG, Symons NL. A survey of cardiopulmonary bypass perfusion practices in Australia in 1992.Anaesth Intens Care 1993;21(6):814–821.

    CAS  Google Scholar 

  45. Naik SK, Knight A, Elliott M. A prospective randomized study of a modified technique of ultrafiltration during pediatric open-heart surgery.Circulation 1991;84(5 suppl):442 –431.

    Google Scholar 

  46. Nagatsu M, Harada Y, Takeuchi T. Initial ultrafiltration to the priming solution with preserved blood for cardiopulmonary bypass in infants.Kyobu Geka 1995;48(4):281–285.

    PubMed  CAS  Google Scholar 

  47. Groom RC, Al BF, Albus RA, et al. Alternative method of ultrafiltration after cardiopulmonary bypass.Ann Thorac Surg 1994;58(2):573–574.

    PubMed  CAS  Google Scholar 

  48. Elliott MJ. Ultrafiltration and modified ultrafiltration in pediatric open heart operations.Ann Thorac Surg 1993;56(6)1518–1522.

    PubMed  CAS  Google Scholar 

  49. Millar AB, Armstrong L, van der Linden J, et al. Cytokine production and hemofiltration in children undergoing cardiopulmonary bypass.Ann Thorac Surg 1993;56(6):1499–1502.

    PubMed  CAS  Google Scholar 

  50. Behr D, Hernvann A, Pouard P, et al. Interleukin-6 and C-reactive protein during pediatric cardiopulmonary bypass.Clin Chem 1995;41(3):467–469.

    PubMed  CAS  Google Scholar 

  51. Journois D, Pouard P, Greeley WJ, et al. Hemofiltration during cardiopulmonary bypass in pediatric cardiac surgery. Effects on hemostasis, cytokines, and complement components.Anesthesiology 1994;81(5):1181–1189.

    PubMed  CAS  Google Scholar 

  52. Withington DE, Man WK, Elliott MJ. Histamine release during paediatric cardiopulmonary bypass.Can J Anaesth 1993;40(4):334–339.

    PubMed  CAS  Google Scholar 

  53. Kriesmer P, Payne NR, Tessmer J, et al. Activated clotting time tests with heparinase in the management of pediatric patients with cardiopulmonary bypass.ASAIO J 1993;39(4):942–945.

    PubMed  CAS  Google Scholar 

  54. Hashimoto K, Yamagishi M, Sasaki T, et al. Heparin and antithrombin III levels during cardiopulmonary bypass: correlation with subclinical plasma coagulation.Ann Thorac Surg 1994;58(3):799–804.

    PubMed  CAS  Google Scholar 

  55. Wang JS, Lin CY, Karp RB. Comparison of high-dose thrombin time with activated clotting time for monitoring of anticoagulant effects of heparin in cardiac surgical patients.Anesth Analg 1994;79(1):9–13.

    PubMed  CAS  Google Scholar 

  56. Litin SC, Gastineau DA. Current concepts in anticoagulant therapy.Mayo Clin Proc 1995;70(3):266–272.

    PubMed  CAS  Google Scholar 

  57. Martin P, Horkay F, Rajah SM, Walker DR. Monitoring of coagulation status using thrombelastography during paediatric open heart surgery. Int J Clin Monit Comput 1991;8(3)183–187.

    PubMed  CAS  Google Scholar 

  58. Szalados JE, Ouriel Shapiro JR. Use of the activated coagulation time and heparin dose-response curve for the determination of protamine dosage in vascular surgery.J Cardiothorac Vas Anesth 1994;8(5):515–518.

    CAS  Google Scholar 

  59. Jobes DR, Aitken GL, Shaffer GW. Increased accuracy and precision of heparin and protamin dosing reduces blood loss and transfusion in patients undergoing primary cardiac operations.J Thorac Cardiovasc Surg 1995;110(1):36–45.

    PubMed  CAS  Google Scholar 

  60. De Laria GA, Tyner JJ, Hayes CL, et al. Heparin-protamine mismatch. A controllable factor in bleeding after open heart surgery. Arch Surg 1994;129(9):944–950.

    Google Scholar 

  61. Jon LC, Rees GM, Kovacs IB. Different anticoagulants and platelet reactivity in cardiac surgical patients.Ann Thorac Surg 1993;56(4):899–902.

    Google Scholar 

  62. Kondo NI, Maddi R, Ewenstein BM, et al. Anticoagulation and hemostasis in cardiac surgical patients.J Cardiovasc Surg 1994;9(4):443–461.

    CAS  Google Scholar 

  63. Del Re MR, Ayd JD, Schultheis LW, et al. Protamine and left ventricular function: a transesophageal echocardiography study.Anesth Analg 1993;77(6):1098–1103.

    PubMed  Google Scholar 

  64. Brister SJ, Ofosu FA, Buchanan MR. Thrombin generation during cardiac surgery: is heparin the ideal anticoagulant?Thromb Haemost 1993;70(2):259–262.

    PubMed  CAS  Google Scholar 

  65. Reich DL, Yanakakis MJ, Vela-Cantos FP, et al. Comparison of bedside coagulation monitoring tests with standard laboratory tests in patients after cardiac surgery.Anesth Analg 1993;77(4):673–679.

    PubMed  CAS  Google Scholar 

  66. Kam PC. Use of desmopressin (DDAVP) in controlling aspirin-induced coagulopathy after surgery.Heart Lung 1994;23(4):333–336.

    PubMed  CAS  Google Scholar 

  67. Salzman EW, Weinstein MJ, Reilly D, et al. Adventures in hemostasis. Desmopressin in cardiac surgery.Arch Surg 1993;128(2):212–217.

    PubMed  CAS  Google Scholar 

  68. Dilthey G, Dietrich W, Spannagl M, et al. Influence of desmopressin acetate on homologous blood requirements in cardiac surgical patients pretreated with aspirin.J Cardiothorac Vase Anesth 1993;7(4):425–430.

    CAS  Google Scholar 

  69. Temeck BK, Bachenheimer LC, Katz NM, et al. Desmopressin acetate in cardiac surgery: a double-blind, randomized study.South Med J 1994;87(6):611–615.

    PubMed  CAS  Google Scholar 

  70. Reynolds LM, Nicholson SC, Jobes DR, et al. Desmopressin does not decrease bleeding after cardiac operation in young children. J Thorac Cardiovasc Surg 1993;106(6)954–958.

    PubMed  CAS  Google Scholar 

  71. Sloan EM, Alyono D, Klein HG, et al. 1-Deamino-8-D-arginine vasopressin (DDAVP) increases platelet membrane expression of glycoprotein lb in patients with disorders of platelet function and after cardiopulmonary bypass.Am J Hematol 1994;46(3):199–207.

    Google Scholar 

  72. Temeck BK, Bachenheimer LC, Katz NM, et al. Desmopressin acetate in cardiac surgery: a double-blind, randomized study.South Med J 1994;87(6):611–615.

    PubMed  CAS  Google Scholar 

  73. Cattaneo M, Pareti FI, Sighetti M, et al. Platelet aggregation at high shear is impaired in patients with congenital defects of platelet secretion and is corrected by DDAVP: correlation with the bleeding time.J Lab Clin Med 1995;125(4):540–547.

    PubMed  CAS  Google Scholar 

  74. Sheridan DP, Card RT, Pinilla JC, et al. Use of desmopressin acetate to reduce blood transfusion requirements during cardiac surgery in patients with acetylsalicylic-acid-induced platelet dysfunction.Can J Surg 1994;37(1):33–36.

    PubMed  CAS  Google Scholar 

  75. Rocha E, Hildago F, Llorens R, et al. Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery.Circulation 1994;90:921–927.

    PubMed  CAS  Google Scholar 

  76. Daily PO, Lamphere JA, Dembitsky WP, et al. Effect of prophylactic epsilon-aminocaproic acid on blood loss and transfusion requirements in patients undergoing first-time coronary artery bypass grafting.J Thorac Cardiovasc Surg 1994;108(1):99–108.

    PubMed  CAS  Google Scholar 

  77. Djulbegovic B, Hannan MM, Bergman GE. Concomitant treatment with factor IX concentrates and antifibrinolytics in hemophilia B.Acta Haematol 1995;94(suppl 1):43–47.

    PubMed  CAS  Google Scholar 

  78. de Peppo AP, Pierri MD, Scafuri A, et al. Intraoperative antifibrinolysis and blood-saving techniques in cardiac surgery. Prospective trial of 3 antifibrinolytic drugs. Tex Heart Inst J 1995;22(3):231–236.

    Google Scholar 

  79. Ranucci M, Como A, Pavesi M, et al. Renal effects of low dose aprotinin in pediatric cardiac surgery. Minerva Anesthesiol 1994;60(7–8):361–366.

    CAS  Google Scholar 

  80. Levy JH, Bailey JM, Salmenpera M. Pharmacokinetics of aprotinin in preoperative cardiac surgical patients. Anesthesiology 1994;80(5):1013–1018.

    PubMed  CAS  Google Scholar 

  81. Davis R, Whittington R. Aprotinin. A review of its pharmacology and therapeutic efficacy in reducing blood loss associated with cardiac surgery.Drugs 1995;49(6):954–983.

    PubMed  CAS  Google Scholar 

  82. Elliot MJ, Allen A. Aprotinin in pediatric cardiac surgery. Perfusion 1990;5:73.

    Google Scholar 

  83. Dietrich W, Mossinger H, Spannagl M, et al. Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations.J Thorac Cardiovasc Surg 1993;105(4):712–720.

    PubMed  CAS  Google Scholar 

  84. Bodt J, Zickmann B, Schindler E, et al. Influence of aprotinin on the thrombomodulin/protein C system in pediatric cardiac operations.J Thorac Cardiovasc Surg 1994;107(5):1215–1221.

    Google Scholar 

  85. Herynkopf F, Lucchese F, Pereira E, et al. Aprotinin in children undergoing correction of congenital heart defects. A double-blind pilot study.J Thorac Cardiovasc Surg 1994;108(3):517–521.

    PubMed  CAS  Google Scholar 

  86. Edmunds LH Jr. Invited letter concerning: aprotinin use in pediatric cardiac operations.J Thorac Cardiovasc Surg 1993;105(4):705–711.

    Google Scholar 

  87. Dietrich W, Mossinger H, Spannagl M, et al. Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations.J Thorac Cardiovasc Surg 1993;105(4):712–720.

    PubMed  CAS  Google Scholar 

  88. Huang H, Ding W, Su Z, et al. Mechanism of the preserving effect of aprotinin in platelet function and its use in cardiac surgery.J Thorac Cardiovasc Surg 1993;106(1):11–18.

    PubMed  CAS  Google Scholar 

  89. Karaski JM, Teasdale SJ, Norman P, et al. Prevention of bleeding after cardiopulmonary bypass with high-dose tranexamic acid. Double-blind, randomized clinical trial.J Thorac Cardiovasc Surg 1995;110(3):835–842.

    Google Scholar 

  90. Boughenou F, Madi-Jebara S, Massonet-Castel S, et al. Fibrinolytic inhibitors and prevention of bleeding in cardiac valve surgery. Comparison of tranexamic acid and high dose aprotinin.Arch Mai Coeur Vais 1995;88(3):363–370.

    CAS  Google Scholar 

  91. Corbeau JJ, Monrigal JP, Jacob JP, et al. Comparison of effects of aprotinin and tranexamic acid on blood loss in heart surgery.Ann Fr Anesth Reanim 1995;14(2):154–161.

    PubMed  CAS  Google Scholar 

  92. Cofey, A, Pittman J, Halbrook H, et al. The use of tranexamic acid to reduce postoperative bleeding following cardiac surgery: a double-blind randomized trial.Am Surg 1995:61(7):566–568.

    Google Scholar 

  93. Arom KV, Emery RW. Decreased postoperative drainage with addition of epsilon-aminocaproic acid before cardiopulmonary bypass.Ann Thorac Surg 1994;57(5):1108–1112.

    PubMed  CAS  Google Scholar 

  94. Haidet KK. Aminocaproic acid.Neonatal Netw 1995;14(3):75–77.

    PubMed  CAS  Google Scholar 

  95. Delrossi AJ, Cernaianu AC, Botros S, et al. Prophylactic treatment of postperfusion bleeding using EACA.Chest 1989;96:27–30.

    PubMed  CAS  Google Scholar 

  96. VanderSalm TJ, Ansell JE, Okike ON, et al. The role of epsilon-aminocaproic acid in reducing bleeding after cardiac operation: a double-blind randomized study.J Thorac Cardiovasc Surg 1988;95:538–540.

    CAS  Google Scholar 

  97. Wilson JM, Bower LK, Fackler JC, et al. Aminocaproic acid decreases in the incidence of intracranial hemorrhage and other hemorrhagic complications of ECMO.J Pediatr Surg 1993;28(4):536–540.

    PubMed  CAS  Google Scholar 

  98. Contrearas M, Ala FA, Greaves M, et al. Guidelines for the use of fresh frozen plasma. British Committee for Standards in Haematology, Working Party of the Blood Transfusion Task Force.Transfus Med 1992;2(2):97–98.

    Google Scholar 

  99. Goodnough LT, Despotis GJ, Hogue CW Jr, et al. On the need for improved transfusion indicators in cardiac surgery.Ann Thorac Surg 1995;60(2):473–480.

    PubMed  CAS  Google Scholar 

  100. Brown MM, Kemper KM. Control of postoperative bleeding in the cardiac surgery patient.J Cardiovasc Nurs 1993;7(4):59–70.

    PubMed  CAS  Google Scholar 

  101. Speiss BD. Cardiac anesthesia risk management. Hemorrhage, coagulation and transfusions risk-benefit analysis.J Cardiothorac Vase Anesth 1994;81(1 suppl 1):19–22.

    Google Scholar 

  102. Lefevre P. Which technique should be chosen to reuse blood loss intraoperatively? Does the type of surgery constitute any contraindication for reutilization (cancer, infection)?Ann Fr Anesth Reamin 1995;15(suppl 1):53–62.

    Google Scholar 

  103. Petaja J, Lunddstrom U, Leijala M, et al. Bleeding and use of blood products after heart operations in infants.J Thorac Cardiovasc Surg 1995;109(3):524–529.

    PubMed  CAS  Google Scholar 

  104. Atsumi N, Abe M, Sakakibara Y, et al. Influence of ionized calcium concentration during cardiopulmonary bypass on pediatric cardiac surgery.Kyobu Geka 1994;47(7):544–548.

    PubMed  CAS  Google Scholar 

  105. Gunning KA, Sugru M, Sloane D, et al. Hypothermia and severe trauma.Aust NZ J Surg 1995;65(2):80–82.

    CAS  Google Scholar 

  106. Phillips GR 3rd, Kauder DR, Schwab CW. Massive blood loss in trauma patients. The benefits and dangers of transfusion therapy. Postgrad Medv 1994;(4):61–62, 67–72.

    Google Scholar 

  107. Phillips GR 3rd, Kauder DR, Schwab CW. Massive blood loss in trauma patients. The benefits and dangers of transfusion therapy. Postgrad Medv 1994;(4):61–62, 67–72.

    Google Scholar 

  108. Muntean W, Zenz W, Finding K, et al. Inhibitor to factor V after exposure to fibrin sealant during cardiac surgery in a two-year old child.Acta Paediatr 1994;83(1):84–87.

    PubMed  CAS  Google Scholar 

  109. Matsuoka S. Screening for post-transfusion hepatitis C—importance of enrollment and recall of blood transfusion recipients.Nippon Kosbu Eisei Zasshi 1994;41(9):933–937.

    CAS  Google Scholar 

  110. Matsuoka S, Tatara K, Hayabuchi Y, et al. Post-transfusion chronic hepatitis C in children.J Paediatr Child Health 1994;30(6):544–546.

    PubMed  CAS  Google Scholar 

  111. Ni YH, Chang MH, Lue HC, et al. Posttransfusion hepatitis C virus infection in children.J Pediatr 1994;125(5 pt 1):709–713.

    Google Scholar 

  112. Frederick T, Mascola L, Eller A, et al. Progression of human immunodeficiency virus disease among infants and children infected perinatally with human immunodeficiency virus or through neonatal blood transfusion. Los Angeles County Pediatric AIDS Consortium and the Los Angeles County-University of Southern California Medical Center and the University of Southern California School of Medicine.Pediatr Infect Dis J 1994;13(2):1091–1097.

    PubMed  CAS  Google Scholar 

  113. Bowden RA, Slichter SJ, Sayers M, et al. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant.Blood 1995;86(9):3599–3603.

    Google Scholar 

  114. Bocsan IS, Neamtu A, Radulescu A, et al. The markers of hepatitis B, C and D viral infection in multiply transfused patients.Bacteriol Virusol Parazitol Epidemiol 1995;40(2):109–113.

    PubMed  CAS  Google Scholar 

  115. Xu D, Yonetani M, Uetani Y, et al. Acquired cytomegalovirus infection and blood transfusion in preterm infants.Acta Paediatr Jpn 1995;37(4):444–449.

    PubMed  CAS  Google Scholar 

  116. Delage G. Transfusion-transmitted infections in the newborn. Transfus Med Rev 1995;9(3):271–276.

    PubMed  CAS  Google Scholar 

  117. Wright JG, McGeer AJ, Chyatte D, et al. Exposure rates to patients’ blood for surgical personnel. 1993;114(5):897–901.

    CAS  Google Scholar 

Download references

Authors
  1. Jeffrey P. Gold
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Cardiothoracic Surgery, The New York Hospital-Cornell Medical Center, 10021, New York, NY, USA

    Karl H. Krieger M.D. (Professor and Vice Chairman) & O. Wayne Isom M.D. (Professor and Chairman) (Professor and Vice Chairman) &  (Professor and Chairman)

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag New York, Inc.

About this chapter

Cite this chapter

Gold, J.P. (1998). Blood Conservation for Infants and Children Undergoing Surgery for Acquired and Congenital Heart Diseases. In: Krieger, K.H., Isom, O.W. (eds) Blood Conservation in Cardiac Surgery. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-2180-7_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-2180-7_8

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-94908-6

  • Online ISBN: 978-1-4612-2180-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation